Etats-Unis: Dr Felicia KNAUL

Elections-UICC Felicia-Knaul


BIOGRAPHY

Felicia M. Knaul is a cancer survivor and an academic with over 130 publications. She is Associate Professor at Harvard Medical School, Director of the Harvard Global Equity Initiative, and co-Director of the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries. She lead authored the report “Closing the Cancer Divide”. She is also Senior Economist at the Mexican Health Foundation with extensive experience in designing and evaluating healthcare systems. Felicia founded the Mexican non-profit Cáncer de Mama:Tómatelo a Pecho to promote research and advocacy in Latin America, and published a testimonial book.

MOTIVATION FOR JOINING THE UICC BOARD OF DIRECTORS

I will bring extensive research and policy experience in global health and cancer. My skills as a health economist, health systems practitioner, advocate and policy advisor in various contexts are of particular relevance to the UICC Board of Directors.My contributions to UICC have always sought to forge links between health systems experts, broader organisations working on health systems and UICC to promote relevant institutional partnerships globally, i.e. linking efforts of the WHO-ADG for Family, Women’s and Children’s Health with that of UICC. The Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries (GTF.CCC), which I co-directed, has been most appreciative of UICC’s participation. I have engaged with UICC leadership and staff on institutional strengthening activities, conducted significant institutional analysis on UICC in the GT.CCC report, made recommendations to help strengthen the Board of Directors through developing country representation, and more broadly contributed to the strategy to increase general membership. Through my advocacy efforts and from my academic base, I have pushed forward UICC priorities, i.e. through joint work with GAPRI to reduce the cancer divide. I have actively participated in and drew leaders to the World Cancer Congress and the World Cancer Leaders’ Summit, as well as represented UICC at global meetings. I strategised with UICC around the UNHLM-NCD, including through NCD Child. I have promoted the dialogue between UICC, Mexican policy-makers and civil society organisations and helped organise and participated in the World Cancer Day event in Mexico with the Minister of Health.

Félicitations au Dr Jamal KHADER pour sa réélection au Board de l'UICC

Elections-UICC Jamal-Khader

BIOGRAPHY

Dr Jamal Khader is a consultant Radiation oncologist at King Hussein Cancer Center in Amman, Jordan. He is Director of the International Affairs Center and the Director of the Radiation oncology Residency programme, Head of the Lung Cancer Service, and serves on several institutional committees such as the Graduate Medical Education Committee. Dr Khader is a member of local, regional and international committees and associations. He is the Chairman of the scientific committee of the Jordanian OncologySociety, and member of the editorial board of the Pan Arab Oncology journal as well as a member in the Jordanian Chapter of the Mediterranean Task Force for Cancer Control.

MOTIVATION FOR JOINING THE UICC BOARD OF DIRECTORS

Serving as the Director of the International Affairs Center, I have extensive knowledge and network with top regional and international key players in cancer treatment and control. I am also heavily involved in training and education initiatives that work on providing opportunities for our staff in the International arena, as well as training programmes hosted at KHCC for local and regional cancer specialists.As UICC Board Member over the past couple of years I believe that UICC’s presence and impact in the Arab world is of significant importance and aligns well with UICCtargets.  I am proud to represent the Middle East in UICC and represent the UICC in the Middle East. I’m sure I will be able to encourage cancer health workers in this region of the world to be involved actively in different UICC activities.  UICC has significantlyimpacted professionals across the world in strengthening and providing opportunities for training and education.  Being a fellow of the UICC myself I feel it would be of value to work on training, education and fellowship and advocacyprogrammes.Over the past few years of my participation in different UICC activities including my current position as member of Board of Directors, I have been involved in adhoc committees such as fellowship and training committee, the World Cancer Declaration task force, a member of the membership committee beside active participation in the annual Cancer Summits and Board meetings.

Brésil: Dr. Maira CALEFFI

Elections-UICC Maira-Caleffi


BIOGRAPHY

MD and PhD. Dr Caleffi is Head of the Breast Centerat Hospital Moinhos de Vento and coordinator of Nucleo Mama Porto Alegre. She holds Pharmacy and Medicine degrees and a residency in Gynecology and Obstetrics. She completed her doctoral thesis at the University of London, and undertook postdoctoral studies in molecular biology in genetics and breast cancer at Vanderbilt University. Dr Caleffi is the founder and the olunteer President of IMAMA and FEMAMA. She is a member of The Brazilian Association of Palliative Care; Brazilian Breast Cancer Study Group (GBECAM); ASCO; Breast Health Global Initiative (BHGI); The Harvard School of Public Health - GTF.CCC; ISPOR; Unión Latinoamericana Contra el Cáncer de la Mujer (ULACCAM).

MOTIVATION FOR JOINING THE UICC BOARD OF DIRECTORS

As a 20-year veteran in the breast cancer (BC) fight, my life as a doctor and as an individual has been guided by one vision: promote, maintain, educate and restore breast health and eradicate breast cancer as a life threatening disease. I founded IMAMA in 1993 to address the BC problem in my home state where we have the highest BC incidence and increasing mortality rates. FEMAMA, in 2006, was a consequence of the need for a national coalition (currently there are 53 NGOs). I alsostarted the ULACCAM with ACS and other Latin-American institutions. As a breastdedicated academic surgeon, I am involved in BC research projects for low and middleincome countries, improved risk factor and management models, and specialised technical training. International cooperation is needed to expand and share successfulexperiences with other countries not yet involved with UICC. I see the empowerment of patient groups as a key factor to successfully guarantee medical access and treatment in the future for underserved communities. Mutual cooperation and the need to strengthen our grass roots movements with the objective to reduce mortality rates are fundamental. My professional experience and my involvement with ASCO, BHGI, GTF, CCC, ISPORand the Brazilian NTCDs initiative allow me a unique view and insight into cancer issues. The tasks facing UICC in LMICs in the future are serious and challenging; we have to make cancer and its risk factors priorities in our governments' agendas. I am committed to UICC and to accomplishing this task.

Canada: Dr Heather BRYANT

Elections-UICC Heather-Bryant
BIOGRAPHY

Dr Bryant is a public health physician and epidemiologist whose career has focused on population-based cancer control. In 1990, at the Alberta Cancer Board, she implemented the firstpopulation-based breast screening programme in the province. As Vice President of Population Health and Information, she led the cancer registry, population-based research, active screening and prevention programmes, and implementation of the patient electronic health record. In 2008, she joined the Canadian Partnership Against Cancer as Vice President Cancer Control, and is implementing the Canadian cancer control strategy with partners throughout the country. She has chaired many national committees in cancer control, screening, and research.

MOTIVATION FOR JOINING THE UICC BOARD OF DIRECTORS

My work in cancer control has built partnerships with a wide range of stakeholders in cancer prevention, screening and care delivery systems – the public, policymakers, professionals, health agencies, and many others – and mobilising these teams to reach significant cancer control outcomes. In my current position with the CanadianPartnership Against Cancer (CPAC), a non-governmental agency mandated to implement the national cancer control strategy, it is critical to build relationships that allow us to synergize activity and accelerate progress, while recognising that the actual care and healthcare management decisions are made by our partners in their own jurisdictions. This is similar to the potential global role of the UICC, and thus I believe this experience will be of value. I have had several international roles, including membership on the Governing Council for the International Agency for Research on Cancer (IARC), as an executive member of the International Association of Cancer Registries (IACR) (contributing to the measurement of the global cancer burden), as a Board Member for the International Cancer Benchmarking Programmeme (an international analysis of survival and public attitudes towards cancer), and on a cancer control working group for the World Health Organisation (WHO). With the UICC, I have been a member of the Strategic Coordinating Committee (attending Board meetings), co-led the Prevention stream for the 2010 UICC Congress, and co-chaired the Scientific ProgrammeCommittee for the 2012 Congress. I look forward to assisting the UICC to develop significant global leadership in cancer control as a Board Member.

Etats-Unis: M. Greg BONTRAGER

Elections-UICC Greg-Bontrager


BIOGRAPHY

As the chief operating officer for theAmerican Cancer Society, Greg Bontrager oversees operations for the world’s largest voluntary health organisation. He provides leadership and direction to all functions of the Society, including its expanding global endeavours. He also supervises the Society’s non-partisan 501(c)(4) advocacy affiliate, theAmerican Cancer Society Cancer Action Network. Mr Bontrager has worked for ACS for over 20 years. Since becoming enterprise COO, he has represented the Society at numerous international events and his interest in expanding the Society’s global mission is well known. He presently oversees the Society’s initiative to develop an enterprise-wide global strategy.

MOTIVATION FOR JOINING THE UICC BOARD OF DIRECTORS

The American Cancer Society values its longstanding relationship with the UICC as a member and strategic partner. I would be honoured to contribute my time and talents towards furthering the UICC’s mission, and believe I could do so most effectively in the following priority areas: • Transforming the global landscape for cancer control and impact: In 2010, our CEO Dr John Seffrin announced his intention to strategically reinvent the American Cancer Society by building an ever-better platform for maximizing mission delivery. Dr Seffrin refers to me as his partner in this endeavour and I am proud of my role in providing a more effective, efficient and nimble platform from which to advance the Societys domestic and global mission. • High-level global conferences, roundtables and meetings: As a key member of the Society’s delegations to many UICC conferences and global corporate leadership events in Asia, Latin America, Africa and Europe, I have engaged corporate leaders on the need to address the global tobacco threat, prioritise cancer control and promote the economic toll of cancer and other NCDs.• The Global Access to Pain Relief Initiative (GAPRI): I am particularly interested in this joint UICC/ACS initiative and would value greater involvement in achieving the goals and objectives of this important collaboration. If elected, I am confidentmy experience and knowledge of the cancer space, as well as the rigours of running a complex organisation within that space, will allow me to contribute greatly to the continued success of this renowned institution.